An Extension of the TG1101-RMS201 Trial

Clinical trial NCT03381170 · COMPLETED

Trial details

NCT number: NCT03381170
Sponsor: TG Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2017-06-01
Primary completion: 2022-11-11
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.